TL;DR
A study from Northwestern Medicine indicates that measuring apolipoprotein B (apoB) offers a more accurate assessment of cardiovascular risk than standard LDL cholesterol tests. This could impact millions of Americans currently tested with LDL alone.
New research from Northwestern Medicine suggests that millions of Americans may be receiving less accurate cholesterol assessments, as apolipoprotein B (apoB) testing could better identify those at risk for heart attacks and strokes than the standard LDL cholesterol test. The study, published in JAMA, found that using apoB to guide treatment decisions improves health outcomes and is cost-effective, potentially prompting a shift in clinical practice.
The study analyzed three cholesterol testing strategies—LDL cholesterol, non-HDL cholesterol, and apoB—using a computer model of 250,000 U.S. adults eligible for statin therapy. Results showed that apoB-based treatment guidance consistently prevented more cardiovascular events and improved overall health outcomes compared to the other methods.
According to the lead author, Ciaran Kohli-Lynch, assistant professor of preventive medicine at Northwestern University Feinberg School of Medicine, “We found that apoB testing to intensify cholesterol-lowering medication would prevent more heart attacks and strokes than current practice, and that these health benefits were achieved at a cost that represents good value for U.S. healthcare payers.” The findings support the idea that apoB, which measures the total number of harmful particles in the blood, offers a more direct indicator of cardiovascular risk than traditional cholesterol tests.
Despite the growing evidence, apoB testing remains underused in routine care, partly due to additional costs and the need for extra blood tests. The study addresses whether the benefits justify these additional expenses, concluding that the improved health outcomes make it a cost-effective approach.
Implications for Heart Disease Prevention Strategies
This research suggests that adopting apoB testing more widely could lead to earlier and more accurate identification of individuals at risk for heart disease, potentially reducing the incidence of heart attacks and strokes. As guidelines increasingly recommend earlier intervention, precise testing becomes essential for targeted treatment, which could improve patient outcomes and optimize healthcare spending.
Apolipoprotein B Test – Evaluate Your Risk of Developing a CVD – Home Testkit – CLIA Certified Laboratory Analysis – Verisana
✅ CHECK: Your Apolipoprotein B level helps you evaluating your risk of developing a cardiovascular disease (CVD).
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Growing Evidence Supporting ApoB’s Predictive Power
For years, clinicians have relied on LDL and non-HDL cholesterol levels to guide treatment decisions. However, recent studies, including this one, indicate that apoB better captures the number of atherogenic particles that contribute to plaque formation. The study aligns with updated guidelines from the American Heart Association and other organizations, emphasizing the need for more accurate risk assessment tools as the number of available cholesterol-lowering medications expands.
“We found that apoB testing to intensify cholesterol-lowering medication would prevent more heart attacks and strokes than current practice, and that these health benefits were achieved at a cost that represents good value for U.S. healthcare payers.”
— Ciaran Kohli-Lynch
CURO-L7 Professional Grade Blood Cholesterol Testing with Home KIT – All-in-One Test Device, Test Strips 5ea, Lancets, and EziTube Rod Included
✅ ALL-IN-ONE KIT: Includes everything needed for testing – Test device, 5 Test strips, Lancets, and EziTube Rod….
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Remaining Questions About Widespread Adoption
It is not yet clear how quickly or widely healthcare providers will adopt apoB testing as a standard practice. Additional research may be needed to confirm these findings across diverse populations and real-world settings, as current data are based on computer models and simulations.
Apolipoprotein B Test – Evaluate Your Risk of Developing a CVD – Home Testkit – CLIA Certified Laboratory Analysis – Verisana
✅ CHECK: Your Apolipoprotein B level helps you evaluating your risk of developing a cardiovascular disease (CVD).
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Next Steps in Cholesterol Testing Research and Practice
Further clinical studies are expected to evaluate the real-world impact of implementing apoB testing on a broader scale. Policy updates and insurance coverage decisions will likely follow, influencing how cholesterol testing is integrated into routine cardiovascular risk assessment.
CURO L7 Portable Cholesterol & Glucose Testing Kit, Easy at-Home Use, Instant 6-in-1 Lipid Panel & Blood Sugar Results, Total, HDL, LDL, Triglycerides, Glucose
✅ Comprehensive 6-in-1 Lipid Panel + Glucose Test: Get fast, lab-accurate readings for Total Cholesterol, Triglycerides, HDL, LDL,…
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
Why is apoB testing considered more effective than LDL testing?
ApoB measures the total number of harmful cholesterol particles in the blood, providing a more direct assessment of cardiovascular risk than LDL cholesterol levels, which only measure the amount of cholesterol carried by particles.
Will apoB testing replace LDL testing in routine care?
This remains uncertain. While evidence supports its benefits, widespread adoption depends on further validation, cost considerations, and clinical guidelines updates.
Is apoB testing more expensive than traditional cholesterol tests?
Yes, it generally requires an additional blood test, which can increase costs. However, the study indicates that the health benefits and potential healthcare savings justify the expense.
How might this change current treatment guidelines?
Guidelines may be updated to recommend apoB testing as a preferred method for risk assessment, especially for patients at intermediate risk or those not responding well to standard therapy.
What should patients do now?
Patients should discuss with their healthcare providers about their current cholesterol testing and whether additional testing, like apoB, might be appropriate based on individual risk factors.
Source: rss
